Pharmaceutical

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Meeting will be reconvened on Friday, June 14, 2024 at 10:00 a.m. Eastern Time  PHILADELPHIA, June 13, 2024 /PRNewswire/ --…

4 months ago

Cole-Parmer Is Back in Peristaltic Pumps

VERNON HILLS, Ill., June 13, 2024 /PRNewswire/ -- Cole-Parmer, an Antylia Scientific company, is pleased to reintroduce peristaltic pumps to…

4 months ago

NIIMBL and Open Applications Group (OAGi) partner to develop open-source biopharmaceutical manufacturing ontologies

NEWARK, Del. and ATLANTA, June 13, 2024 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has contributed…

4 months ago

FDA clears Clario’s SpiroSphere® with wireless ECG, streamlining data collection in clinical trials

With the FDA 510(k) clearance of the COR-12 wireless ECG device now integrated with the SpiroSphere®, sponsors can conduct comprehensive…

4 months ago

Cosmos Health Completes Acquisition of Pelofarm’s Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million

CHICAGO, IL / ACCESSWIRE / June 13, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

4 months ago

SpendMend’s Trulla Software Platform Chosen to Optimize Pharmacy Procurement at Froedtert Health

GRAND RAPIDS, MI / ACCESSWIRE / June 13, 2024 / SpendMend, a leading provider of solutions to optimize the cost-cycle…

4 months ago

FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications

TORONTO, ON / ACCESSWIRE / June 13, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to…

4 months ago

Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial

Phase 1b/2a open-label trial in the U.S. of certepetide in combination with neoadjuvant FOLFIRINOX based therapies in pancreatic, colon and…

4 months ago

Aphaia Pharma Completes Enrollment in Arm 2 of Phase 2 Trial in Individuals with Obesity

Enrollment has been completed for the last four cohorts evaluating the contribution of circadian effects in weight loss treatment using…

4 months ago

Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility

Signed PO secures first 12 months of syringe product orders against Sharps and Nephron’s five-year, $200 million Syringe Sales Agreement.…

4 months ago